-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS ANNOUNCES TRANSFORMATIVE PRECLINICAL DATA DEMONSTRATING PAXALISIB'S POTENTIAL TO OVERCOME IMMUNOTHERAPY RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Reuters·06/11/2025 12:00:14

Please log in to view news